home / stock / edsa / edsa news


EDSA News and Press, Edesa Biotech Inc. From 02/09/24

Stock Information

Company Name: Edesa Biotech Inc.
Stock Symbol: EDSA
Market: NYSE
Website: edesabiotech.com

Menu

EDSA EDSA Quote EDSA Short EDSA News EDSA Articles EDSA Message Board
Get EDSA Alerts

News, Short Squeeze, Breakout and More Instantly...

EDSA - Edesa Biotech GAAP EPS of -$0.54 beats by $0.67

2024-02-09 16:23:01 ET More on Edesa Biotech Seeking Alpha’s Quant Rating on Edesa Biotech Historical earnings data for Edesa Biotech Financial information for Edesa Biotech Read the full article on Seeking Alpha For further details see: Ed...

EDSA - Expected US Company Earnings on Friday, February 9th, 2024

Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...

EDSA - Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

TORONTO, ON / ACCESSWIRE / January 4, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that company management plans to participate in the 2024 Dermatology Summi...

EDSA - EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023

2023-12-18 05:51:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Edesa Biotech (NASDAQ: EDSA ) just reported results for the fourth quarter of 2023. Edesa Biotech reported earnings per share of -55 cents. This was above the analyst esti...

EDSA - Edesa Biotech Reports Fiscal Year 2023 Results

TORONTO, ON / ACCESSWIRE / December 15, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the fiscal year ended September 30, 2023 and provid...

EDSA - Expected US Company Earnings on Friday, December 15th, 2023

Industrial & Commercial Bank of China Ltd. ADR (IDCBY) is expected to report for Q3 2023 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 Bexil Corp (BXLC) is expected to report for quarter end 2023-09-30 Timberline Resources Corp. (TLRS) is expected to report...

EDSA - Expected earnings - Edesa Biotech Inc.

Edesa Biotech Inc. (EDSA) is expected to report $-0.71 for Q4 2023

EDSA - PAVM, CCLD and EDSA among mid-day movers

2023-12-12 12:30:31 ET Gainers: C4 Therapeutics ( CCCC ) +85% . Aditxt ( ADTX ) +71% . Icosavax ( ICVX ) +48% . IN8bio ( INAB ) +31% . Petros Pharmaceuticals ( PTPI ) +31% . Clean Earth Acquisitions Corp ( CLIN ) +26% ...

EDSA - Alterity Therapeutics, Edesa Biotech among healthcare movers

2023-11-22 10:00:14 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

EDSA - Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

1.0% Formulation Reached Primary Endpoint with Statistical Significance Full Analysis Identified Additional Efficacy Signals TORONTO, ON / ACCESSWIRE / November 20, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-r...

Previous 10 Next 10